Global Hemoglobin Monitor Market Size study, By Product Type (Connectivity, Wired, Non-wired, Convenience, Invasive, Non-invasive), By Modality (Handheld, Bench Top, Modular), By End User (Hospital, Ambulatory Surgical Centre’s, Specialty Clinic, Home care setting, Healthcare Facilities, Emergency Medical Services), and Regional Forecasts 2022-2028
Global Hemoglobin Monitor Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Hemoglobin Monitor refers to medical devices utilized for measuring hemoglobin and hematocrit levels in the whole blood. Hemoglobin tests are done to know the RBC count, to analyze the severity of anaemia, and hematocrit among others. It is also used during blood donations and blood transfusions procedures. The rising awareness towards continues monitoring of blood and increasing per capita health care spending as well as recent product innovations from leading market players are accelerating the global market demand. For instance, according to Statista – in 2020, the global market for blood glucose monitoring systems was estimated at USD 15.67 billion, and this amount is further projected to increase to USD 22 billion by 2026. Furthermore, leading market are introducing innovative products to capitalize increasing demand for compact hemoglobin monitors. For instance, in January 2021, Bosch launched its new AI based Hemoglobin Monitor Solution (HMS). This new system is intended for regions where access to routine medical care is difficult and cumbersome process. Also, growing technological advancements in healthcare sector and rising healthcare sector in emerging economies are anticipated to act as a catalyzing factor for the market demand during the forecast period. However, high cost associated with hemoglobin monitoring devices impede the growth of the market over the forecast period of 2022-2028.
The key regions considered for the global Hemoglobin Monitor Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the growing technological advancements in healthcare industry and presence of leading market players in the region. Whereas, Asia Pacific is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as growing adoption of eHealth devices and increasing penetration of global market players in the region, would create lucrative growth prospects for the global Hemoglobin Monitor Market across the Asia Pacific region.
Major market players included in this report are:
Masimo Corporation
Bayer AG
Siemens Healthineers
Welch Allyn, Inc.
Koninklijke Philips N.V
Medtronic plc
Nihon Kohden Corporation
GE Healthcare
Smith’s Group
Omron Healthcare.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type:
Connectivity
Wired
Non-wired
Convenience
Invasive
Non-invasive
By Modality:
Handheld
Bench Top
Modular
By End User:
Hospital
Ambulatory Surgical Centre’s
Specialty Clinic
Home care setting
Healthcare Facilities
Emergency Medical Services
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global Hemoglobin Monitor Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Companies Mentioned
Masimo Corporation
Bayer AG
Siemens Healthineers
Welch Allyn, Inc.
Koninklijke Philips N.V
Medtronic plc
Nihon Kohden Corporation
GE Healthcare
Smith’s Group
Omron Healthcare.
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook